(:CFMS)

Sep 05, 2023 08:18 am ET
restor3d Completes Acquisition of Conformis
restor3d, Inc. and Conformis, Inc. announced today that restor3d has completed its previously announced acquisition of Conformis following the approval of Conformis’ stockholders at a special meeting held on August 31, 2023. In connection with the...
Aug 23, 2023 08:00 am ET
Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Conformis Stockholders Vote “FOR” the Pending Merger with restor3d
Conformis, Inc. (NASDAQ:CFMS), a leading medical technology company featuring personalized knee and hip replacement products, announced today that leading independent proxy advisory firms, Institutional Shareholder Services Inc. (“ISS”) and Glass...
Aug 21, 2023 04:10 pm ET
Independent Proxy Advisory Firm ISS Recommends Conformis Stockholders Vote “FOR” the Pending Merger with restor3d
Conformis, Inc. (NASDAQ:CFMS), a leading medical technology company featuring personalized knee and hip replacement products, announced today that leading independent proxy advisory firm, Institutional Shareholder Services Inc. (“ISS”), has...
Aug 09, 2023 10:37 am ET
Moore Kuehn Encourages TRTN, CFMS, AMED, and NEX Investors to Contact Law Firm
Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek...
Aug 02, 2023 05:15 pm ET
Conformis Reports Second Quarter 2023 Financial Results
Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the second quarter ended June 30, 2023. Second Quarter 2023 Summary Total...
Aug 01, 2023 12:04 pm ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NEWR, SURF, CFMS
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: New Relic, Inc. (NYSE: NEWR)’s sale to...
Aug 01, 2023 11:19 am ET
Moore Kuehn Encourages PACW, NEWR, CFMS, and SURF Investors to Contact Law Firm
Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek...
Aug 01, 2023 03:56 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NETI, TALS, QUOT, CFMS
NEW YORK, Aug. 1, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Jul 25, 2023 03:00 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AEL, SGTX, CFMS
NEW YORK, July 25, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Jul 24, 2023 07:42 pm ET
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – AJX, PDCE, CFMS, SGTX
Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered...
Jul 18, 2023 10:39 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NETI, QUOT, TALS, CFMS
NEW YORK, July 18, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Jul 17, 2023 05:16 pm ET
ALERT: The M&A Class Action Firm Continues Investigating the Merger – PDCE, SGTX, CFMS, SYNH
Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered...
Jul 15, 2023 08:07 pm ET
Lifshitz Law PLLC Announces Investigations of KLR, CFMS, TALS, and SGTX
Kaleyra, Inc. (NYSE: KLR) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of KLR to Tata Communications Limited for $7.25 per share in cash. If you are a KLR investor, and...
Jul 11, 2023 07:38 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DICE, QUOT, TALS, CFMS
NEW YORK, July 11, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Jul 10, 2023 09:30 pm ET
ALERT: The M&A Class Action Firm Continues Investigating the Merger – CFMS, PRTK, NETI, WMC
Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and...
Jun 29, 2023 12:15 pm ET
IMPORTANT ALERT: Halper Sadeh LLC Investigates KLR, QUOT, CFMS
NEW YORK, June 29, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Jun 28, 2023 10:32 pm ET
ALERT: The M&A Class Action Firm Continues Investigating the Merger – KLR, CFMS, NETI, WMC
Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and...
Jun 26, 2023 09:19 am ET
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Conformis, Inc. (Nasdaq – CFMS), Eneti Inc. (NYSE – NETI), Franchise Group, Inc. (Nasdaq – FRG), NexTier Oilfie
Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ([email protected]) or Marc Ackerman ([email protected]) at 855-576-4847. There is no...
Jun 25, 2023 08:33 am ET
IMPORTANT ALERT: Halper Sadeh LLC Investigates TALS, SURF, CFMS
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Talaris Therapeutics, Inc. (NASDAQ:...
Jun 24, 2023 09:09 pm ET
CONFORMIS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Conformis, Inc. - CFMS
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Conformis, Inc. (NasdaqCM: CFMS) to restor3d, Inc. Under the terms of the proposed transaction, shareholders of Conformis will receive $2.27 in cash for each share of Conformis that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
Jun 23, 2023 06:31 pm ET
Shareholder Alert: Ademi LLP investigates whether Conformis, Inc. has obtained a Fair Price in its transaction with restor3d
MILWAUKEE, June 23, 2023 /PRNewswire/ -- Ademi LLP is investigating Conformis (NASDAQ: CFMS) for possible breaches of fiduciary duty and other violations of law in its transaction with restor3d. 
Jun 23, 2023 12:14 pm ET
IMPORTANT ALERT: Halper Sadeh LLC Investigates CFMS, DFFN, ARNC, GRNA
NEW YORK, June 23, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Jun 23, 2023 09:31 am ET
Thinking about buying stock in Xpeng, Nio, Applied Optoelectronics Inc, ConforMIS, or Applied DNA Sciences?
NEW YORK, June 23, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for XPEV, NIO, AAOI, CFMS, and APDN.
Jun 23, 2023 09:01 am ET
CFMS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Conformis, Inc. Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Conformis, Inc. (NASDAQ: CFMS) to restor3d for $2.27 per share in cash is fair to Conformis shareholders.
Jun 22, 2023 10:05 pm ET
Conformis Announces Definitive Agreement to be Acquired by restor3d for a Purchase Price of $2.27 Per Share in Cash
restor3d, Inc. and Conformis, Inc. (NASDAQ: CFMS) announced today that they have entered into a definitive merger agreement under which restor3d, a leading personalized 3D-printed orthopedic company, will acquire all outstanding shares of common...
May 08, 2023 08:05 am ET
Conformis Reports First Quarter 2023 Financial Results
Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the first quarter ended March 31, 2023. First Quarter 2023 Summary Total...
Apr 13, 2023 04:30 pm ET
Conformis, Inc. to Announce Financial Results for Its First Quarter on May 8, 2023
Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it will release its financial results for the first quarter ended March 31, 2023, before the market opens...
Mar 21, 2023 07:00 am ET
Conformis Launches Patient Awareness Campaign to Highlight the Benefits of Personalized Knee Replacement Procedures
Conformis, Inc. (NASDAQ:CFMS), a leading medical technology company featuring personalized knee and hip replacement products, recently launched a patient education and awareness campaign in selected U.S. markets to strengthen the importance of...
Mar 01, 2023 04:05 pm ET
Conformis, Inc. Reports Fourth Quarter and Year End 2022 Financial Results
Conformis, Inc. (NASDAQ:CFMS) an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the fourth quarter and year ended December 31, 2022. Fourth Quarter 2022 Summary...
Feb 21, 2023 04:15 pm ET
Conformis, Inc. to Participate in Upcoming Investor Conferences
Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial Officer, will participate at...
Feb 15, 2023 04:15 pm ET
Conformis, Inc., Bodycad Laboratories, Inc. and Bodycad USA Corp. Announce Settlement of Patent Litigation
Conformis, Inc. (NASDAQ:CFMS) along with Bodycad Laboratories, Inc. and Bodycad USA Corp. announced today that they have entered into a settlement and license agreement that resolves the patent infringement dispute filed by Conformis in June of...
Feb 10, 2023 07:00 am ET
Conformis Provides Business Update and Reports Preliminary Results for Fourth Quarter and Full-Year 2022
Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, provided today a business update and reported preliminary financial results for the fourth quarter and year ended...
Jan 23, 2023 04:30 pm ET
Conformis, Inc. to Announce Financial Results for Its Fourth Quarter and Full-Year 2022
Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it will release its financial results for the fourth quarter and full-year ended December 31, 2022, after...
Nov 30, 2022 04:30 pm ET
Conformis, Inc. Regains Compliance with Nasdaq’s Minimum Bid Price Rule
Conformis, Inc. (NASDAQ:CFMS) announced today that it received a letter from the Listing Qualifications Department of The NASDAQ Stock Market (“NASDAQ”) on November 25, 2022 notifying Conformis that, based on the closing bid price of Conformis’...
Nov 29, 2022 07:30 am ET
Conformis Announces First Procedure Performed Using New Actera™ Hip System
Conformis, Inc. (NASDAQ:CFMS), a leading medical device company that features personalized knee and hip replacement products, today announced that the first procedure with the company’s new Actera™ Hip System has been performed. Dr. William...
Nov 17, 2022 07:00 am ET
Conformis Announces Full Commercial Launch of Imprint™
Conformis, Inc. (NASDAQ:CFMS), a leading medical technology company featuring personalized knee and hip replacement products, today announced the full commercial launch of its new Imprint™ knee system. This launch marks the formal transition to its...
Nov 14, 2022 04:15 pm ET
Conformis, Inc. Announces Settlement of Medacta Patent Litigation
Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a settlement and license agreement with Medacta USA, Medacta Germany GmbH, and Medacta International SA (together, “Medacta”) that resolves all patent disputes between the...
Nov 09, 2022 07:00 am ET
Conformis, Inc. Effects 1-for-25 Reverse Stock Split
Conformis, Inc. (NASDAQ:CFMS) (“Conformis”) announced that it will effect a 1-for-25 reverse stock split at 5:00 p.m. Eastern time today. Beginning with the opening of trading on November 10, 2022, Conformis’ common stock will trade on the Nasdaq...
Nov 02, 2022 04:10 pm ET
Conformis Reports Third Quarter 2022 Financial Results
Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the third quarter ended September 30, 2022. Third Quarter 2022 Summary Total...
Oct 05, 2022 04:30 pm ET
Conformis, Inc. to Announce Financial Results for Its Third Quarter 2022
Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it will release its financial results for the third quarter ended September 30, 2022, after the market...
Sep 13, 2022 04:30 pm ET
Conformis Actera™ Hip System Receives 510(k) Clearance from the U.S. Food and Drug Administration
Conformis, Inc. (NASDAQ:CFMS), a leading medical technology company featuring personalized knee and hip replacement products, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for the Company’s Actera™...
Aug 29, 2022 04:30 pm ET
Conformis, Inc. to Participate in the H.C. Wainwright & Co. 24th Annual Global Investment Conference
Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial Officer, will participate in...
Aug 08, 2022 04:45 pm ET
Conformis Reports Second Quarter 2022 Financial Results
Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the second quarter ended June 30, 2022. Second Quarter 2022 Summary Total...
Aug 01, 2022 04:30 pm ET
Conformis Announces New Agreement with Vizient for Personalized Orthopedic Implants
Conformis, Inc., (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, today announced it has entered into a multi-year agreement with Vizient, Inc., the nation's largest member-driven health...
Jul 28, 2022 04:30 pm ET
Conformis, Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference
Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial Officer, will participate in...
Jul 05, 2022 04:30 pm ET
Conformis, Inc. to Release Second Quarter 2022 Financial Results on August 8, 2022
Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it will release its financial results for the second quarter ended June 30, 2022, after the market closes...
May 24, 2022 08:00 am ET
Conformis Highlights New Clinical Study Findings that Knee Shapes are Highly Individualized and are Not Determined by Identifiers, Including Gender, Body Type, or Ethnicity
Conformis, Inc. (NASDAQ:CFMS), a leading medical device company that features personalized knee and hip replacement products, today announced results of a published study that investigated the characteristic shapes of knees to see if typical...
May 10, 2022 08:00 am ET
Conformis, Inc. to Participate in the H.C. Wainwright Global Investment Conference
Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial Officer, will participate in...
May 04, 2022 07:00 am ET
Conformis Reports First Quarter 2022 Financial Results
Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the first quarter ended March 31, 2022. First Quarter 2022 Summary Total...
Apr 11, 2022 04:30 pm ET
Conformis, Inc. to Release First Quarter 2022 Financial Results on May 4, 2022
Conformis, Inc. (NASDAQ: CFMS) announced today it will release its financial results for the first quarter ended March 31, 2022, before the market opens on Wednesday, May 4, 2022, at approximately 7:00 a.m. Eastern Time. Mark Augusti, CEO, and Bob...
Apr 01, 2022 05:00 pm ET
Conformis, Inc. Appoints Michael Fillion as Chief Operating Officer
Conformis, Inc. (NASDAQ:CFMS), announced today that Michael Fillion has joined the Company as its Chief Operating Officer. “We are pleased to announce the addition of Michael Fillion as Chief Operating Officer. Mike brings to this role 30 years of...
Mar 22, 2022 08:00 am ET
Conformis Partners with Synchrony to Offer CareCredit Financial Services to Orthopedic Patients
Conformis, Inc. (NASDAQ: CFMS), the pioneer and leader of fully personalized knee and hip replacement systems, today announced a strategic marketing partnership with Synchrony (NYSE: SYF) that will add the innovative Image-to-Implant® Platinum...
Mar 14, 2022 04:30 pm ET
Conformis, Inc. Appoints Denise Pedulla as Chief Legal Officer and Corporate Secretary
Conformis, Inc. (NASDAQ:CFMS) announced today that Denise Pedulla has joined the Company as its Chief Legal Officer and Corporate Secretary. “We are pleased to announce the addition of Denise Pedulla as Chief Legal Officer and Corporate Secretary....
Mar 11, 2022 08:00 am ET
Gary Fischetti nominated to join Conformis’ Board of Directors
Conformis, Inc. (NASDAQ:CFMS), announced today that Gary P. Fischetti has been nominated to stand for election to the Company’s Board of Directors at the Company’s 2022 Annual Meeting of Stockholders, scheduled to be held on May 4, 2022. Mr....
Mar 02, 2022 04:05 pm ET
Conformis, Inc. Reports Fourth Quarter and Year End 2021 Financial Results
Conformis, Inc. (NASDAQ:CFMS) an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the fourth quarter and year ended December 31, 2021. Fourth Quarter 2021 Summary...
Mar 02, 2022 08:00 am ET
Conformis Suspends All Distribution Operations and Business Development in Russia
Conformis, Inc. (NASDAQ:CFMS), announced that it was suspending all distribution operations to Russia and any Russian-based entities for its orthopedic medical devices. Additionally, until further notice, the company will no longer pursue future...
Feb 28, 2022 08:00 am ET
New Clinical Study Finds Bilateral Knee Patients Prefer Conformis’ Fully Personalized Solution Over Competitive Off-the-Shelf Implants by a Factor of Over 10 to 1
Conformis, Inc. (NASDAQ:CFMS), the pioneer and leader of fully personalized orthopedic medical devices, today announced results of a published retrospective study of patients showing the superiority of Conformis’ implants in several key measures of...
Feb 24, 2022 08:00 am ET
Conformis iTotal® CR Knee Replacement System Awarded “7A” Performance Rating from the U.K.’s Orthopaedic Data Evaluation Panel
Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, today announced that the Orthopaedic Data Evaluation Panel in the United Kingdom (ODEP) awarded the Conformis iTotal®...
Feb 18, 2022 04:30 pm ET
Conformis, Inc. to Participate in Upcoming Investor Conferences
Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial Officer, will participate in...
Jan 20, 2022 04:30 pm ET
Conformis, Inc. to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 2, 2022
Conformis, Inc. (NASDAQ: CFMS) announced today that as mentioned on its Business Update call on January 6, 2022, it will release its financial results for the fourth quarter and fiscal year ended December 31, 2021, after the market closes on...
Jan 06, 2022 07:00 am ET
Conformis, Inc. Provides Business Update and Initial Expectations for 2022
Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, today announced preliminary revenue results from its fourth quarter 2021, initial expectations for 2022, and a...
Jan 04, 2022 08:30 am ET
Conformis, Inc. to Provide Business Update and Initial Expectations for 2022 on January 6, 2022
Conformis, Inc. (NASDAQ: CFMS) announced today that it will provide a business update and initial expectations for 2022 before the market opens on Thursday, January 6, 2022, at approximately 7:00 a.m. Eastern Time. Mark Augusti, CEO, and Bob Howe,...
Dec 23, 2021 08:30 am ET
Conformis, Inc. Announces Departure of Chief Legal Officer, Corporate Secretary
Conformis, Inc. (NASDAQ:CFMS) announced today that Brent Alldredge, Chief Legal Officer and Corporate Secretary, has notified the Company that he will be departing the Company on January 16, 2022 to become the General Counsel at Bruker Corporation,...
Nov 08, 2021 09:00 am ET
Conformis, Inc. Appoints James Paiva as its new Vice President of U.S. Marketing; Inducement Grant Reported
Conformis, Inc. (NASDAQ:CFMS) announced today that the Company has appointed James Paiva as its new Vice President, U.S. Marketing. “Conformis is pleased to welcome James Paiva as the new V.P. of U.S. Marketing. As we continue to advance our...
Nov 03, 2021 04:05 pm ET
Conformis Reports Third Quarter 2021 Financial Results
Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the third quarter ended September 30, 2021. Third Quarter 2021 Summary Total...
Oct 04, 2021 05:00 pm ET
Conformis, Inc. to Release Third Quarter 2021 Financial Results on November 3, 2021
Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the third quarter ended September 30, 2021 after the market closes on November 3, 2021 at approximately 4:00 p.m. Eastern Time. Mark Augusti, CEO,...
Sep 29, 2021 05:00 pm ET
Conformis, Inc. Announces Strong Clinical Study Results for Its Personalized Knee Implants
Conformis, Inc. (NASDAQ:CFMS) announced today the strong results of a published retrospective study of procedures using Conformis’ patient-specific iTotal® CR (cruciate-retaining) knee replacement implant, which assessed implant survivorship,...
Sep 20, 2021 04:30 pm ET
Conformis, Inc. Provides Business Update
Conformis, Inc. (NASDAQ:CFMS) provided today an update of its third quarter revenue performance expectations in advance of the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (“OpCo Summit”). The Company has experienced higher than...
Sep 07, 2021 05:00 pm ET
Conformis, Inc. to Participate in Upcoming Investor Conferences
Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features a range of personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial Officer, will...
Aug 18, 2021 05:00 pm ET
Conformis, Inc. Announces First Procedure Performed Using the Identity Imprint™ Knee Replacement System
Conformis, Inc. (NASDAQ:CFMS) today announced the first procedure with the new Conformis Identity Imprint knee replacement system. Identity Imprint, available in both cruciate retaining (CR) and posterior stabilized (PS) implants, utilizes a...
Aug 04, 2021 04:05 pm ET
Conformis Reports Second Quarter 2021 Financial Results
Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the second quarter ended June 30, 2021. Second Quarter 2021 Summary...
Aug 04, 2021 09:31 am ET
Thinking about buying stock in Beyondspring, Tupperware, MGM Growth Properties, Xenetic Biosciences, or ConforMIS?
NEW YORK, Aug. 4, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BYSI, TUP, MGP, XBIO, and CFMS.
Jul 23, 2021 08:30 am ET
Thinking about buying stock in Veoneer, Abeona Therapeutics, ConforMIS, Neurobo Pharmaceuticals, or Acutus Medical?
NEW YORK, July 23, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VNE, ABEO, CFMS, NRBO, and AFIB.
Jul 20, 2021 09:31 am ET
Thinking about buying stock in Immunome, Aldeyra Therapeutics, New Oriental Education, ConforMIS, or Cytokinetics?
NEW YORK, July 20, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for IMNM, ALDX, EDU, CFMS, and CYTK.
Jul 19, 2021 08:30 am ET
Thinking about buying stock in Cytokinetics, Property Solutions Acquisition, Imara, ConforMIS, or Sesen Bio?
NEW YORK, July 19, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CYTK, PSAC, IMRA, CFMS, and SESN.
Jul 15, 2021 09:31 am ET
Thinking about buying stock in Cinedigm, Arlo Technologies, Velodyne Lidar, Jaguar Health, or ConforMIS?
NEW YORK, July 15, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CIDM, ARLO, VLDR, JAGX, and CFMS.
Jul 14, 2021 05:45 pm ET
Conformis, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference
Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial Officer, will present at...
Jul 07, 2021 07:30 am ET
Conformis, Inc. Announces Settlement of Wright Medical Patent Litigation
Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a settlement with Stryker Corporation (“Stryker”) resolving patent litigation involving Wright Medical Technology, Inc. and Tornier, Inc. (together, “Wright Medical”). Stryker...
Jul 01, 2021 05:00 pm ET
Conformis, Inc. to Release Second Quarter 2021 Financial Results on August 4, 2021
Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the second quarter ended June 30, 2021 after the market closes on August 4, 2021 at approximately 4:00 p.m. Eastern Time. Mark Augusti, CEO, and Bob...
Jun 23, 2021 08:30 am ET
Thinking about buying stock in ConforMIS, Citius Pharmaceuticals, Clover Health, Capricor Therapeutics, or Dare Bioscience?
NEW YORK, June 23, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CFMS, CTXR, CLOV, CAPR, and DARE.
Jun 23, 2021 07:30 am ET
Conformis, Inc. Announces Exclusive Distribution Agreement in China
Conformis, Inc. (NASDAQ:CFMS) today announced the execution of an agreement to enter the Asia-Pacific market through an exclusive distribution relationship with XR Medical Group (Hong Kong) Limited (XR Medical). Under the distribution agreement,...
May 18, 2021 08:15 am ET
Conformis, Inc. to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit
Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, will present at the Oppenheimer MedTech, Tools &...
May 12, 2021 06:10 pm ET
Conformis, Inc. to Present at the Canaccord Genuity Musculoskeletal Conference
Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial Officer, will present at...
May 10, 2021 07:30 am ET
Conformis, Inc. Announces 510(k) Clearance for Identity Imprint™ Knee Replacement System
Conformis, Inc. (NASDAQ:CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration for the Company’s Identity Imprint Knee Replacement System. Identity Imprint is a new total knee replacement system, available in both cruciate...
May 05, 2021 04:05 pm ET
Conformis Reports First Quarter 2021 Financial Results
Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the first quarter ended March 31, 2021. First Quarter 2021 Summary Total...
Apr 22, 2021 04:30 pm ET
Conformis Announces Achievement of Third Milestone Under Development and License Agreements
Conformis, Inc. (NASDAQ:CFMS) announced today that it received 510(k) clearance by the U.S. Food and Drug Administration for patient-specific instrumentation (“PSI”) developed by the Company under its License Agreement and Development Agreement...
Apr 19, 2021 04:30 pm ET
Conformis Announces License Agreement with Paragon 28
Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a license agreement with Paragon 28, Inc., granting Paragon 28 a non-exclusive license under a subset of Conformis’ U.S. patents for the use of patient-specific instruments with...
Apr 07, 2021 07:30 am ET
Conformis, Inc. to Release First Quarter 2021 Financial Results on May 5, 2021
Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the first quarter ended March 31, 2021 after the market closes on May 5, 2021 at approximately 4:00 p.m. Eastern Time. Mark Augusti, CEO, and Bob Howe,...
Mar 16, 2021 07:00 am ET
Clinical Study: Patient-Specific Total Knee Replacement with Conformis Technology Is More Cost-Effective Than with Leading Off-the-Shelf Implants
Conformis, Inc. (NASDAQ:CFMS) announced today that an independent, retrospective review of hospital data has concluded that Conformis iTotal® knee replacement technology is more cost-effective than leading traditional, off-the-shelf implants....
Mar 03, 2021 04:05 pm ET
Conformis, Inc. Reports Fourth Quarter and Year End 2020 Financial Results
Conformis, Inc. (NASDAQ:CFMS) announced today financial results for the fourth quarter and year ended December 31, 2020. Fourth Quarter 2020 Summary Total revenue of $16.7 million, a decrease of 16% year-over-year on a reported basis and 17% on a...
Mar 01, 2021 05:45 pm ET
Conformis, Inc. Announces Clearance in Australia for iTotal® PS, the Only Personalized, Posterior-Stabilized Total Knee Replacement System
Conformis, Inc. (NASDAQ: CFMS) today announced the clearance of its patient-specific iTotal® PS total knee replacement system by the Therapeutic Goods Administration, which is part of the Australian Department of Health, and which authorizes the...
Feb 25, 2021 08:00 am ET
Conformis, Inc. to Participate in Upcoming Investor Conferences
Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial Officer, will participate at...
Feb 22, 2021 07:30 am ET
Thinking about buying stock in Celsion Corp, Can Fite Biopharma, ConforMIS Inc, Citius Pharmaceuticals, or Vuzix Corp?
NEW YORK, Feb. 22, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CLSN, CANF, CFMS, CTXR, and VUZI.
Feb 12, 2021 08:30 am ET
Conformis, Inc. Announces Pricing of $85 Million Underwritten Offering of Common Stock
Conformis, Inc. (Nasdaq: CFMS) today announced it has priced an underwritten public offering of 80,952,381 shares of its common stock at an offering price of $1.05 per share. The gross proceeds from the offering will be approximately $85 million,...
Feb 11, 2021 04:01 pm ET
Conformis, Inc. Announces Proposed Public Offering of Common Stock
Conformis, Inc. (Nasdaq: CFMS) today announced that it intends to offer shares of its common stock in an underwritten public offering. Conformis intends to grant the underwriters a 30-day option to purchase additional shares of its common stock...
Jan 21, 2021 04:15 pm ET
Conformis, Inc. and SITES Medical Announce Development & Supply Agreement
Conformis, Inc. (NASDAQ:CFMS) and SITES Medical, a firm dedicated to inventing and de-risking new orthopedic medical device technologies, today announced they have entered into a non-exclusive development and supply agreement. The companies will...
Jan 07, 2021 08:00 am ET
Conformis, Inc. to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 3, 2021
Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the fourth quarter and fiscal year ended December 31, 2020 after the market closes on March 3, 2021 at approximately 4:00 p.m. Eastern Time. Mark...
Dec 31, 2020 08:30 am ET
Conformis, Inc. to Participate in Upcoming Investor Conferences
Conformis, Inc. (NASDAQ: CFMS), a leader in patient-specific knee and hip instrumentation and implants, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial Officer, will participate in two virtual investor...
Dec 17, 2020 04:15 pm ET
Conformis Announces U.S. Commercial Launch of Cordera™ Match Hip System
Conformis, Inc. (NASDAQ: CFMS) announced today the U.S. commercial launch of the Company’s new Cordera™ Match Hip System. The Company previously announced 510(k) clearance by the U.S. Food and Drug Administration for the Cordera™ Hip System on...
Nov 24, 2020 04:30 pm ET
Conformis, Inc. to Participate in the 32nd Annual Piper Sandler Healthcare Conference
Conformis, Inc. (NASDAQ:CFMS) announced today that Mark Augusti, President and Chief Executive Officer, and Robert Howe, Chief Financial Officer, will participate in the 32nd Annual 2020 Piper Sandler Virtual Healthcare Conference taking...
Nov 09, 2020 04:30 pm ET
Conformis Announces Bart Lagae as VP, International Sales & Marketing; Inducement Grant Reported
Conformis, Inc. (NASDAQ:CFMS) announced today that the Company has appointed Bart Lagae as its new VP, International Sales & Marketing. “We are pleased to announce that Bart Lagae has joined our team as VP, International Sales & Marketing. Bart...
Nov 04, 2020 04:10 pm ET
Conformis Reports Third Quarter 2020 Financial Results
Conformis, Inc. (NASDAQ:CFMS) announced today financial results for the third quarter ended September 30, 2020. Third Quarter 2020 Summary Total revenue of $16.1 million, a decrease of 7% year-over-year on a reported and constant currency...
Oct 28, 2020 06:30 pm ET
Conformis, Inc. to Participate in the 2020 Oppenheimer Fall MedTech Summit
Conformis, Inc. (NASDAQ:CFMS) announced today that Mark Augusti, President and Chief Executive Officer, and Robert Howe, Chief Financial Officer, will participate in the virtual 2020 Oppenheimer Fall MedTech Summit taking place Thursday, November...
Oct 06, 2020 07:30 am ET
Conformis Reports Preliminary Third Quarter Revenue Results
Conformis, Inc. (NASDAQ:CFMS) today announced preliminary, unaudited, revenue results for the third quarter ended September 30, 2020. Expected Q3 Summary: Total revenue of approximately $16.1 million, down 7% year-over-year on a reported and...
Sep 29, 2020 10:45 am ET
Conformis Announces 510(k) Clearance for Cordera™ Hip System
Conformis, Inc. (NASDAQ: CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration of the Company’s new Cordera™ Hip System. The first product in the Conformis hip product line, the Conformis Hip System, was launched...
Sep 24, 2020 07:00 am ET
Conformis, Inc. Announces $17.25 Million Registered Direct Offering Priced At-The-Market
Conformis, Inc. (Nasdaq: CFMS) today announced it has entered into a definitive agreement with a healthcare focused institutional investor to sell to the investor, in a registered direct offering priced at-the-market under Nasdaq rules, (i)...
Sep 16, 2020 04:30 pm ET
Conformis, Inc. to Present at the 2020 Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Conformis, Inc. (NASDAQ:CFMS) will participate in the 2020 Oppenheimer Fall Healthcare Life Sciences & MedTech Summit being held September 21-23, 2020 in a virtual format.  Mark Augusti, President and Chief Executive Officer, and Robert Howe, Chief...
Sep 08, 2020 04:30 pm ET
Conformis, Inc. to Present at the 2020 H.C. Wainwright Global Investment Conference
Conformis, Inc. (NASDAQ:CFMS) will participate in the upcoming 2020 H.C. Wainwright 22nd Annual Global Investment Conference, to be held virtually on September 14-16, 2020.  Mark Augusti, President and Chief Executive Officer, and members of the...
Sep 02, 2020 05:30 pm ET
Conformis, Inc. to Participate in the 2020 Wells Fargo Virtual Healthcare Conference
Conformis, Inc. (NASDAQ:CFMS) announced today that Mark Augusti, President and Chief Executive Officer, and members of the Company’s executive management team will participate in the 2020 Wells Fargo Virtual Healthcare Conference taking place...
Aug 20, 2020 07:30 am ET
Conformis Announces Achievement of Second Milestone Under Development and License Agreements
Conformis, Inc. (NASDAQ:CFMS) announced today that it completed the second of three milestones pursuant to the License Agreement and Development Agreement with Howmedica Osteonics Corp., a wholly owned subsidiary of Stryker Corporation also known...
Aug 13, 2020 05:15 pm ET
Conformis Announces Farzin Khaghani as VP, US Marketing; Inducement Grants Reported
Conformis, Inc. (NASDAQ:CFMS) announced today that the Company has appointed Farzin Khaghani as its new VP, US Marketing. “We are very pleased to announce that Farzin Khaghani has rejoined our team as VP, US Marketing. Farzin’s product expertise...
Aug 10, 2020 09:25 am ET
90% Patient Satisfaction Reported in Peer-Reviewed Clinical Study of Conformis iTotal PS Knee Replacements
Conformis, Inc. (NASDAQ:CFMS) announced today that 90% of the patients studied in peer-reviewed clinical research published online in The Journal of Bone and Joint Surgery Reviews were satisfied, or very satisfied, 18–28 months post-surgery. In...
Aug 05, 2020 04:10 pm ET
Conformis Reports Second Quarter 2020 Financial Results and Announces Planned Portfolio Expansion Targeted at Ambulatory Surgical Centers
Conformis, Inc. (NASDAQ:CFMS) announced today financial results for the second quarter ended June 30, 2020. Second Quarter 2020 Summary Total revenue of $19.5 million, a decrease of 1% year-over-year on a reported and constant currency...
Jul 23, 2020 05:00 pm ET
Conformis, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference
Conformis, Inc. (NASDAQ:CFMS) announced today that management will present at the Canaccord Genuity 40th Annual Growth Conference. The event is being held virtually and will take place between August 11 and 13, 2020.  For more information, please...
Jul 06, 2020 07:30 am ET
Conformis Reports Preliminary Second Quarter Revenue Results, Amendment to Credit Agreement
Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants designed to fit each patient’s unique anatomy, today...
Jun 22, 2020 07:38 am ET
Conformis Announces 510(k) Clearance for iTotal® Identity PS
Conformis, Inc. (NASDAQ:CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration of the Company’s next generation iTotal® Identity PS Knee System. The iTotal® Identity PS Knee System uses proprietary advanced imaging and...
May 28, 2020 07:30 am ET
Conformis Announces Settlement of Patent Dispute
Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a settlement and license agreement with Zimmer Biomet Holdings, Inc., Zimmer, Inc., Zimmer US, Inc., and Biomet Manufacturing, LLC (together, “Zimmer Biomet”) that resolves all...
May 21, 2020 08:00 am ET
Prestigious Klee Family Foundation Prize 2020 Awarded for Outstanding Scientific Work Identifying Patient-Specific Approach as Better Way to Optimize Knee Implant Design
Conformis, Inc. (NASDAQ: CFMS) congratulates Dr. Malte Asseln for winning the prestigious Klee Prize 2020 for his dissertation and computer-and-image-based workflow on the optimization of knee implant design - “Morphological and Functional Analysis...
May 11, 2020 04:19 pm ET
Conformis Reports First Quarter 2020 Financial Results
Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell patient-specific joint replacement implants designed to fit each patient's unique...
May 05, 2020 06:15 pm ET
Conformis to Host First Quarter 2020 Financial Results Webcast on May 11, 2020
Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast and conference call on Monday, May 11, 2020, at 4:30 p.m. Eastern Time to discuss its financial results for the first quarter ended March 31, 2020.  The webcast will be live...
Apr 23, 2020 07:00 am ET
Conformis Announces Return to Work of Furloughed Employees
Conformis, Inc. (NASDAQ:CFMS) announced today that, due in large part to a loan made available to the Company under the Paycheck Protection Program (“PPP Loan”) offered by the U.S. Small Business Administration to qualified small businesses in...
Apr 20, 2020 09:00 am ET
Conformis Receives $4.7 Million under the Paycheck Protection Program
Conformis, Inc. (NASDAQ:CFMS) today announced that on April 17, 2020 the Company entered into a $4,719,800 promissory note with East West Bank (NASDAQ:EWBC) under the Paycheck Protection Program (“PPP”) offered by the U.S. Small Business...
Apr 09, 2020 04:45 pm ET
Conformis to Hold Virtual Annual Meeting of Stockholders on April 27, 2020
Conformis, Inc. (NASDAQ: CFMS) today announced that, due to the public health impact of the novel coronavirus outbreak and governmental restrictions limiting the number of people who may gather together, and to support the health and well-being of...
Mar 23, 2020 07:44 am ET
Conformis Announces Actions to Mitigate COVID-19 Impact
Conformis, Inc. (NASDAQ:CFMS), an orthopedic arthroplasty medical technology company, today announced proactive steps it is taking and planning to mitigate the negative financial and operational impacts of the coronavirus (COVID-19) pandemic. “Our...
Mar 02, 2020 05:45 pm ET
Conformis Reports Fourth Quarter and Year End 2019 Financial Results
Conformis, Inc. (NASDAQ:CFMS), announced today financial results for the fourth quarter and year ended December 31, 2019. Q4 Summary Total revenue of $19.9 million, down 10% year-over-year on a reported basis and 9% on a constant currency...
Feb 21, 2020 08:52 am ET
Conformis, Inc. to Present at the Cowen 40th Annual Health Care Conference
Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell joint replacement implants and instruments that are individually sized and shaped, and...
Feb 20, 2020 04:52 pm ET
Conformis to Host Fourth Quarter and Fiscal Year 2019 Financial Results Webcast on March 2, 2020
Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast and conference call on Monday, March 2, 2020, at 4:30 p.m. Eastern Time to discuss its financial results for the fourth quarter and fiscal year ended December 31, 2019.  The...
Feb 19, 2020 04:44 pm ET
Conformis iTotal® CR Knee Replacement System Awarded “5A” Rating from the Orthopaedic Data Evaluation Panel in the United Kingdom
Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell patient-specific knee and hip joint replacement implants designed to fit each...
Feb 05, 2020 07:45 am ET
Conformis Appoints Bob Howe as Chief Financial Officer
Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell patient-specific knee and hip joint replacement implants designed to fit each...
Jan 30, 2020 07:00 am ET
Conformis Achieves 100,000 Implant Milestone for Patient-Specific Knee Replacement Technology
Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient-specific knee and hip joint replacement implants designed to fit each patient's...
Jan 14, 2020 07:15 am ET
Conformis Reports Preliminary Fourth Quarter and Year-End 2019 Revenue Results
Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants designed to fit each patient’s unique anatomy, today...
Nov 07, 2019 04:45 pm ET
Conformis Announces FDA Clearance and Full Commercial Launch of Next Generation Hip System at the 2019 AAHKS Conference
Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell patient-specific arthroplasty joint replacement implants designed to fit each...
Oct 30, 2019 04:05 pm ET
Conformis Reports Third Quarter 2019 Financial Results
Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient-specific joint replacement implants designed to fit each patient's unique...
Oct 15, 2019 04:15 pm ET
Conformis to Host Third Quarter 2019 Financial Results Webcast on October 30, 2019
Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast on Wednesday, October 30, 2019, at 4:30 p.m. Eastern Time to discuss its financial results for the third quarter ended September 30, 2019.  The webcast will be live at:...
Oct 04, 2019 08:30 am ET
Conformis Announces Departure of Paul Weiner, CFO
Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell patient-specific joint replacement implants designed to fit each patient’s unique...
Oct 01, 2019 08:00 am ET
Conformis and Stryker Execute Development, License and Distribution Agreements
Conformis, Inc. (NASDAQ: CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell patient-specific joint replacement implants designed to fit each patient’s unique...
Aug 06, 2019 10:00 am ET
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Conformis, Inc. (CFMS)
NEW YORK, Aug. 6, 2019 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Conformis, Inc. ("Conformis"  or the Company") (NASDAQ: CFMS). Investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site:  www.bgandg.com/cfms.     
Aug 01, 2019 06:00 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Conformis, Inc. - CFMS
Pomerantz LLP is investigating claims on behalf of investors of  Conformis, Inc. (“Conformis” or the “Company”) (NASDAQ: CFMS). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980. The...
Jul 31, 2019 04:05 pm ET
Conformis Reports Second Quarter 2019 Financial Results and Updates Product Revenue Expectations
Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants designed to fit each patient's unique...
Jul 15, 2019 04:30 pm ET
Conformis Establishes Alliance to Focus on ASC Joint Replacement
Conformis, Inc. (NASDAQ: CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants designed to fit each patient's unique...
Jul 15, 2019 11:30 am ET
Conformis to Host Second Quarter 2019 Financial Results Webcast on July 31, 2019
Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast on Wednesday, July 31, 2019, at 4:30 p.m. Eastern Time to discuss its financial results for the second quarter ended June 30, 2019.  The webcast will be live at:...
Jun 25, 2019 04:15 pm ET
Conformis Secures Up to $30 Million in Debt Financing and $3 Million in Equity Financing from Innovatus Life Sciences and East West Bank
Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants designed to fit each patient's unique...
May 01, 2019 04:05 pm ET
Conformis Reports First Quarter 2019 Financial Results
Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants designed to fit each patient's unique...
Apr 23, 2019 12:05 pm ET
New Peer Reviewed Data Supports Use of Conformis Customized Knee Implants to Match Anatomic Variability in Patients
Conformis Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants customized to fit each patient’s unique anatomy, today...
Apr 17, 2019 04:30 pm ET
Conformis to Host First Quarter 2019 Financial Results Webcast on May 1, 2019
Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast on Wednesday, May 1, 2019, at 4:30 p.m. Eastern Time to discuss its financial results for the first quarter ended March 31, 2019.  The webcast will be live at:...
Mar 13, 2019 08:30 am ET
The 3D designed Conformis Hip System Announced at the 2019 AAOS conference
Conformis Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants customized to fit each patient’s unique anatomy, today...
Feb 22, 2019 08:25 am ET
Research Report Identifies Raytheon, ConforMIS, Extreme Networks, ACI Worldwide, Fortuna Silver Mines, and National Beverage with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Raytheon Company (NYSE:RTN), ConforMIS, Inc. (NASDAQ:CFMS), Extreme Networks,...
Feb 18, 2019 08:30 am ET
Customized Knee Implants Drive Significant Cost Savings in a Medicare Population – Abstract Presented at Annual Knee Society Meeting
Conformis Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants customized to fit each patient’s unique anatomy, today...
Feb 06, 2019 04:05 pm ET
Conformis Reports Fourth Quarter and Year Ended 2018 Financial Results
Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants designed to fit each patient's unique...
Jan 23, 2019 04:10 pm ET
Conformis to Host Fourth Quarter and Fiscal Year 2018 Financial Results Webcast on February 6, 2019
Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast on Wednesday, February 6, 2019, at 4:30 p.m. Eastern Time to discuss its financial results for the fourth quarter and fiscal year ended December 31, 2018.  The webcast will...
Jan 08, 2019 08:00 am ET
Conformis Reports Preliminary Fourth Quarter and Year-End 2018 Revenue Results
Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants designed to fit each patient’s unique anatomy, today...
Dec 18, 2018 02:30 pm ET
Conformis Announces Common Stock Purchase Agreement with Institutional Investor, Lincoln Park Capital Fund
Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants designed to fit each patient’s unique anatomy, today...
Dec 13, 2018 04:10 pm ET
Conformis Announces Strategic Actions to Reach Profitability and Reduce Debt
Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants designed to fit each patient’s unique anatomy, today...
Nov 06, 2018 07:45 am ET
New Research Coverage Highlights Penn National Gaming, PBF Logistics LP, Floor & Decor, Applied Industrial Technologies, ConforMIS, and SMART Global — Consolidated Revenues, Company Growth, and Expect
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Penn National Gaming, Inc. (NASDAQ:PENN), PBF Logistics LP (NYSE:PBFX),...
Oct 31, 2018 04:05 pm ET
Conformis Reports Third Quarter 2018 Financial Results and Updates Fiscal Year 2018 Guidance
Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants designed to fit each patient's unique...
Oct 10, 2018 04:10 pm ET
Conformis to Host Third Quarter 2018 Financial Results Webcast on October 31, 2018
Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast on Wednesday, October 31, 2018, at 4:30 p.m. Eastern Time to discuss its financial results for the third quarter 2018.  The webcast will be live at:...
Sep 17, 2018 08:00 am ET
Conformis Announces Settlement of Patent Dispute with Smith & Nephew
Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that fit each patient's unique anatomy, announced today that...
Sep 05, 2018 08:20 am ET
Report: Developing Opportunities within Powell Industries, ConforMIS, Heska, Gevo, QAD, and Northeast — Future Expectations, Projections Moving into 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Powell Industries, Inc. (NASDAQ:POWL), ConforMIS, Inc. (NASDAQ:CFMS),...
Aug 15, 2018 07:50 am ET
Consolidated Research: 2018 Summary Expectations for FTD Companies, PRA Group, Equity Bancshares, ConforMIS, Immune Design, and Imprimis Pharmaceuticals — Fundamental Analysis, Key Performance Indicat
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of FTD Companies, Inc. (NASDAQ:FTD), PRA Group, Inc. (NASDAQ:PRAA), Equity...
Aug 02, 2018 08:30 am ET
Conformis announces election of Carrie Bienkowski to its Board of Directors
Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy,...
Aug 01, 2018 04:15 pm ET
Conformis Announces the first 3D Total Hip Replacement Surgeries performed at JFK Medical Center in Florida
Conformis, Inc. (NASDAQ:CFMS), a medical technology company that offers patient conforming joint replacement implants, today announced completion of the first two Conformis Hip System implants. The Conformis Hip System is the first ever 3D designed...
Aug 01, 2018 04:05 pm ET
Conformis Reports Second Quarter 2018 Financial Results
Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants designed to fit each patient's unique...
Jul 12, 2018 04:05 pm ET
Conformis to Host Second Quarter 2018 Financial Results Webcast on August 1, 2018
Conformis, Inc. (NASDAQ:CFMS) announced today that it will host a webcast on Wednesday, August 1, 2018, at 4:30 p.m. Eastern Time to discuss its financial results for the second quarter 2018.  The webcast will be live at:...
Jun 26, 2018 11:00 am ET
Peer Reviewed Results: Conformis Patient Specific iTotal CR Achieves Better Rotational Alignment and Tibial Fit Compared to Off-the-Shelf Implants
Conformis Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants designed to fit each patient's unique...
Jun 25, 2018 08:30 am ET
Peer Reviewed Results: Conformis Patient Specific iTotal CR Achieves Better Rotational Alignment and Tibial Fit Compared to Off-the-Shelf Implants
Conformis Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants designed to fit each patient's unique...
May 23, 2018 08:25 am ET
New Research: Key Drivers of Growth for PCM, WGL, Savara, ConforMIS, Sandy Spring, and West Pharmaceutical Services — Factors of Influence, Major Initiatives and Sustained Production
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of PCM, Inc. (NASDAQ:PCMI), WGL Holdings Inc (NYSE:WGL), Savara Inc....
May 02, 2018 04:05 pm ET
Conformis Reports First Quarter 2018 Financial Results
Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy,...
Apr 12, 2018 04:05 pm ET
Conformis to Host First Quarter 2018 Financial Results Conference Call and Webcast on May 2, 2018
BILLERICA, Mass., April 12, 2018 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS) announced today that it will host a conference call on Wednesday, May 2, 2018, at 4:30 p.m. Eastern Time to discuss its financial results for the first...
Mar 30, 2018 07:55 am ET
Market Trends Toward New Normal in ConforMIS, Equity Commonwealth, SendGrid, Granite Point Mortgage Trust, Stewart Information Services, and South State — Emerging Consolidated Expectations, Analyst R
NEW YORK, March 30, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ConforMIS, Inc. (NASDAQ:CFMS), Equity Commonwealth (NYSE:EQC),...
Mar 07, 2018 08:00 am ET
Four-Year Data from the UK National Joint Registry Highlights High Survivorship in Patients Treated with the Conformis iTotal CR
Data Shows a Low Cumulative Percent Revision of 0.5% for Conformis Patients vs 1.9% for all Total Knee Replacement Patients
Mar 01, 2018 08:00 am ET
Feb 07, 2018 04:05 pm ET
ConforMIS Reports Fourth Quarter and the Year Ended 2017 Financial Results; Reiterates 2018 Financial Guidance
BILLERICA, Mass., Feb. 07, 2018 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's...
Feb 07, 2018 12:30 pm ET
ConforMIS Inc to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / February 7, 2018 / ConforMIS Inc (NASDAQ: CFMS) will be discussing their earnings results in their Q4 Earnings Call to be held on February 7, 2018 at 4:30 PM Eastern Time.
Jan 30, 2018 07:40 am ET
Research Report Identifies Shutterstock, Intra-Cellular Therapies, ConforMIS, Jack Henry & Associates, Instructure, and WEX with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
NEW YORK, Jan. 30, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Shutterstock, Inc. (NYSE:SSTK), Intra-Cellular Therapies Inc....
Jan 25, 2018 08:00 am ET
ConforMIS Announces Pricing of Public Offering of Common Stock
BILLERICA, Mass., Jan. 25, 2018 (GLOBE NEWSWIRE) -- ConforMIS,  Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each...
Jan 24, 2018 04:01 pm ET
ConforMIS Announces Proposed Public Offering of Common Stock
BILLERICA, Mass., Jan. 24, 2018 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's...
Jan 08, 2018 04:15 pm ET
ConforMIS Reports Preliminary Fourth Quarter and Year-End 2017 Revenue Results; Provides 2018 Financial Guidance
ConforMIS to Host Fourth Quarter and the Year Ended 2017 Financial Results Conference Call and Webcast on February 7, 2018
Jan 04, 2018 04:15 pm ET
ConforMIS Announces Publication of Results published in the peer-reviewed Journal of Knee Surgery showing 100% of patients treated with iTotal CR achieve mechanical alignment in target range of +/- 3%
BILLERICA, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that offers joint replacement implants designed and manufactured to fit each patient’s unique anatomy, today announced the publication of a prospective study in The...
Nov 01, 2017 04:05 pm ET
ConforMIS Reports Third Quarter 2017 Financial Results
BILLERICA, Mass., Nov. 01, 2017 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy, announced today financial results for the third quarter ended September 30, 2017....
Nov 01, 2017 04:05 pm ET
ConforMIS Reports Third Quarter 2017 Financial Results
BILLERICA, Mass., Nov. 01, 2017 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's...
Oct 12, 2017 04:05 pm ET
ConforMIS to Host Third Quarter 2017 Financial Results Conference Call and Webcast on November 1, 2017
BILLERICA, Mass., Oct. 12, 2017 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS) announced today that it will host a conference call on Wednesday, November 1, 2017, at 4:30 p.m. Eastern Time to discuss its financial results for the third quarter 2017.  To participate in the conference call, please call 877-809-6331 (or 615-247-0224 for international) and use conference ID number 99181599....
Aug 03, 2017 04:05 pm ET
ConforMIS Reports Second Quarter 2017 Financial Results and Updates Fiscal Year 2017 Guidance
BILLERICA, Mass., Aug. 03, 2017 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy, announced today financial results for the second quarter ended June 30, 2017....
Jul 19, 2017 04:05 pm ET
ConforMIS to Host Second Quarter 2017 Financial Results Conference Call and Webcast on August 3, 2017
BILLERICA, Mass., July 19, 2017 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS) announced today that it will host a conference call on Thursday, August 3, 2017, at 4:30 p.m. Eastern Time to discuss its financial results for the second quarter 2017.  To participate in the conference call, please call 877-809-6331 (or 615-247-0224 for international) and use conference ID number 57887575....
May 10, 2017 04:05 pm ET
ConforMIS Reports First Quarter 2017 Financial Results
BILLERICA, Mass., May 10, 2017 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy, announced today financial results for the first quarter ended March 31, 2017....
Apr 11, 2017 04:41 pm ET
ConforMIS to Host First Quarter 2017 Financial Results Conference Call and Webcast on May 10, 2017
BEDFORD, Mass., April 11, 2017 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS) announced today that it will host a conference call on Wednesday, May 10, 2017, at 4:30 p.m. Eastern Time to discuss its financial results for the first quarter 2017.  To participate in the conference call, please call 877-809-6331 (or 615-247-0224 for international) and use conference ID number 5263799....
Feb 15, 2017 04:05 pm ET
ConforMIS Reports Fourth Quarter and the Year Ended 2016 Financial Results; Provides 2017 Financial Guidance
BEDFORD, Mass., Feb. 15, 2017 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy, announced today financial results for the fourth quarter and the year ended December 31, 2016....
Jan 17, 2017 05:10 pm ET
ConforMIS to Host Fourth Quarter and Fiscal Year 2016 Financial Results Conference Call and Webcast on February 15, 2017
BEDFORD, Mass., Jan. 17, 2017 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS) announced today that it will host a conference call on Wednesday, February 15, 2017, at 4:30 p.m. Eastern Time to discuss its financial results for the fourth quarter and fiscal year ended December 31, 2016.  To participate in the conference call, please call 877-809-6331 (or 615-247-0224 for international) and use conference ID number 55924641....
Jan 09, 2017 08:45 am ET
ConforMIS Secures Up to $50 Million in Financing from Oxford Finance and Files Shelf Registration Statement
BEDFORD, Mass., Jan. 09, 2017 (GLOBE NEWSWIRE) -- ConforMIS Inc. (NASDAQ:CFMS), a medical technology company that develops, manufactures and sells joint replacement implants that are customized to fit each patient's unique anatomy, announced today that the Company has secured up to $50 million in debt financing from Oxford Finance LLC.  ConforMIS also announced today that it has filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission ("SEC")....
Nov 03, 2016 04:05 pm ET
ConforMIS Reports Third Quarter 2016 Financial Results
BEDFORD, Mass., Nov. 03, 2016 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy, announced today financial results for the third quarter ended September 30, 2016....
Oct 24, 2016 08:45 am ET
ConforMIS Names Industry Veteran Mark Augusti President and Chief Executive Officer
BEDFORD, Mass., Oct. 24, 2016 (GLOBE NEWSWIRE) -- ConforMIS Inc. (NASDAQ:CFMS), a medical technology company that develops, manufactures and sells joint replacement implants that are customized to fit each patient's unique anatomy, announced today that Mark A. Augusti has been named the Company’s President and Chief Executive Officer, effective when he joins the Company on November 14, 2016.  The Company also expects that Mr. Augusti will be appointed to the Company’s Board of Directors following the commencement of his employment. Mr. Augusti will succeed current President and Chief Executi...
Oct 20, 2016 04:45 pm ET
ConforMIS to Host Third Quarter 2016 Financial Results Conference Call and Webcast on November 3, 2016
BEDFORD, Mass., Oct. 20, 2016 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS) announced today that it will host a conference call on Thursday, November 3, 2016, at 4:30 p.m. Eastern Time to discuss its financial results for the third quarter 2016. To participate in the conference call, please call 877-809-6331 (or 615-247-0224 for international) and use conference ID number 5481072....
Oct 17, 2016 08:00 am ET
ConforMIS Announces Publication of Clinical Study Demonstrating iTotal CR Customized Implants Better Approximate Normal Knee Motion When Compared to a Leading Off-the-Shelf Total Knee Implant
iTotal CR total knee replacementBEDFORD, Mass., Oct. 17, 2016 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that develops, manufactures and sells joint replacement implants that are customized to fit each patient's unique anatomy, today announced that The Journal of Arthroplasty has accepted for printed publication, and published online, the results of an in vivo clinical study comparing the motion patterns of patients with a ConforMIS iTotal® CR implant versus patients with a traditional off-the-shelf total knee implant. The study demonstrated that Confor...
Oct 04, 2016 08:30 am ET
ConforMIS Announces Sale of Over 50,000 Customized Knee Implants
iTotal PS - posterior view.jpgiTotal CR glass bone.jpgBEDFORD, Mass., Oct. 04, 2016 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that develops, manufactures and sells joint replacement implants that are customized to fit each patient's unique anatomy, today announced a significant milestone.  ConforMIS has sold more than 50,000 implants, each individually sized and shaped to fit each patient’s unique anatomy.  Unlike manufacturers of traditional “off-the-shelf” knee replacement implants that offer products with a limited range of sizes and geometries, Con...
Aug 15, 2016 09:30 am ET
Clinical Studies Demonstrate ConforMIS iTotal CR Customized Knee Implants Provide Superior Outcomes and Potential for Economic Savings
BEDFORD, Mass., Aug. 15, 2016 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that develops, manufactures and sells joint replacement implants that are customized to fit each patient's unique anatomy, announced today the results from two clinical studies presented at the ICJR Pan Pacific Orthopaedic Congress, August 10 – 13, 2016....
Aug 08, 2016 04:05 pm ET
ConforMIS Reports Second Quarter 2016 Financial Results and Updates Fiscal Year 2016 Revenue Guidance
BEDFORD, Mass., Aug. 08, 2016 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy, announced today financial results for the second quarter ended June 30, 2016....
Jul 20, 2016 05:30 pm ET
ConforMIS to Host Second Quarter 2016 Financial Results Conference Call and Webcast on August 8, 2016
BEDFORD, Mass., July 20, 2016 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS) announced today that it will host a conference call on Monday, August 8, 2016, at 4:30 p.m. Eastern Time to discuss its financial results for the second quarter 2016.  To participate in the conference call, please call 877-809-6331 (or 615-247-0224 for international) and use conference ID number 47277183....
Jul 06, 2016 08:55 am ET
Study Finds High Satisfaction Amongst Patients with ConforMIS Customized Total Knee Replacements
BEDFORD, Mass., July 06, 2016 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy, announced today interim results from an ongoing, multi-center, prospective study of iTotal CR in the United States, in which more than 300 patients have been enrolled.  The results of the study, which is financially supported by ConforMIS, were presented at the 2016 SICOT International Orthopaedic “...
Jun 21, 2016 08:00 am ET
ConforMIS iTotal® PS Customized Knee Replacement Honored as 2016 Gold Stevie® Award Winner
iTotal PS customized posterior stabilized total knee replacementBEDFORD, Mass., June 21, 2016 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that offers joint replacement implants customized to fit each patient's unique anatomy, today announced that their newest product to market, the iTotal® PS posterior-stabilized total knee replacement system, was named the winner of the Gold Stevie® Award in the Health & Pharmaceuticals Product category. The Stevie Award, presented by The American Business Awards, recognizes businesses and products that represent im...
May 12, 2016 04:05 pm ET
ConforMIS Reports First Quarter 2016 Financial Results and Updates Fiscal Year 2016 Revenue Guidance; Board of Directors Initiates CEO Succession Plan
BEDFORD, Mass., May 12, 2016 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy, announced today financial results for the first quarter ended March 31, 2016....

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.